GridAI Technologies Corp. (GRDX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 5, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of the Preliminary Proxy Statement filed by Entero Therapeutics, Inc. on May 16, 2025. They remind the company and its management of their respons… | Read Filing EDGAR |
| May. 30, 2025 | CORRESP | Concern from SEC | Moderate | The correspondence involves Entero Therapeutics, Inc. responding to comments from the SEC regarding their Revised Preliminary Proxy Statement on Schedule 14A. The SEC raised conce… | Read Filing EDGAR |
| May. 30, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Entero Therapeutics, Inc.'s revised preliminary proxy statement and has raised several comments that require clarification. Specifically, they are seeking mor… | Read Filing EDGAR |
| May. 27, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Entero Therapeutics, Inc. addresses comments from the SEC regarding their Preliminary Proxy Statement on Schedule 14A. The company has made revisions to cl… | Read Filing EDGAR |
| May. 22, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Entero Therapeutics, Inc.'s preliminary proxy statement filed on May 16, 2025, and has issued comments requiring clarification on several points. Specifically… | Read Filing EDGAR |